Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie Ewer, Geraldine O’Hara, C.J. Duncan, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 283

Showing 26-50 of 283 citing articles:

The march toward malaria vaccines
Stephen L. Hoffman, Johan Vekemans, Thomas L. Richie, et al.
Vaccine (2015) Vol. 33, pp. D13-D23
Open Access | Times Cited: 112
Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth Payne, Kathryn H. Milne, Sean C. Elias, et al.
The Journal of Infectious Diseases (2016) Vol. 213, Iss. 11, pp. 1743-1751
Open Access | Times Cited: 109
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
Beatrice Ondondo, Hayato Murakoshi, Genevieve Clutton, et al.
Molecular Therapy (2016) Vol. 24, Iss. 4, pp. 832-842
Open Access | Times Cited: 107
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
George M. Warimwe, Joseph Gesharisha, B. Veronica Carr, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 106
Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
Elena Stylianou, Kristin Griffiths, Hazel Poyntz, et al.
Vaccine (2015) Vol. 33, Iss. 48, pp. 6800-6808
Open Access | Times Cited: 104
Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
Eleni Panagioti, Paul Klenerman, Lian Ni Lee, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 103
Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field
Dragomira Majhen, Hugo Calderón, Naresh Chandra, et al.
Human Gene Therapy (2014) Vol. 25, Iss. 4, pp. 301-317
Closed Access | Times Cited: 97
Multivalent and Multipathogen Viral Vector Vaccines
Katharina B. Lauer, Ray Borrow, Thomas J. Blanchard
Clinical and Vaccine Immunology (2016) Vol. 24, Iss. 1
Open Access | Times Cited: 97
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
Tommy Rampling, Katie Ewer, Georgina Bowyer, et al.
The Journal of Infectious Diseases (2016) Vol. 214, Iss. 5, pp. 772-781
Open Access | Times Cited: 89
New viral vectors for infectious diseases and cancer
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, et al.
Seminars in Immunology (2020) Vol. 50, pp. 101430-101430
Open Access | Times Cited: 86
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
César López‐Camacho, Peter Abbink, Rafael A. Larocca, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 83
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 68
A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion
Debashree Goswami, Hardik Patel, William Betz, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 723-754
Open Access | Times Cited: 15
Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions
Randy Yoo, Matthijs M. Jore, Jean‐Philippe Julien
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Vaccines Against Malaria
Amed Ouattara, Matthew B. Laurens
Clinical Infectious Diseases (2014) Vol. 60, Iss. 6, pp. 930-936
Open Access | Times Cited: 82
Guidelines for the automated evaluation of Elispot assays
Sylvia Janetzki, Leah Price, Hélène Schroeder, et al.
Nature Protocols (2015) Vol. 10, Iss. 7, pp. 1098-1115
Closed Access | Times Cited: 79
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Katie Ewer, Sarah Sebastian, Alexandra J. Spencer, et al.
Human Vaccines & Immunotherapeutics (2017) Vol. 13, Iss. 12, pp. 3020-3032
Open Access | Times Cited: 77
Clinical development of Ebola vaccines
Saranya Sridhar
Therapeutic Advances in Vaccines (2015) Vol. 3, Iss. 5-6, pp. 125-138
Open Access | Times Cited: 75
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
Morven Wilkie, Iman Satti, Alice Minhinnick, et al.
Vaccine (2019) Vol. 38, Iss. 4, pp. 779-789
Open Access | Times Cited: 73
Prime and target immunization protects against liver-stage malaria in mice
Anita Gola, Daniel Silman, Adam A. Walters, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 460
Open Access | Times Cited: 69
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem
David L. Sacks
Nature Immunology (2014) Vol. 15, Iss. 5, pp. 403-405
Open Access | Times Cited: 68
Nanomimics of Host Cell Membranes Block Invasion and Expose Invasive Malaria Parasites
Adrian Najer, Dalin Wu, Andrej Bieri, et al.
ACS Nano (2014) Vol. 8, Iss. 12, pp. 12560-12571
Closed Access | Times Cited: 67
Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections
Geraldine Taylor, Michelle Thom, Stefania Capone, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 300
Closed Access | Times Cited: 64
Vaccination against the Epstein–Barr virus
Julia Rühl, Carol S. Leung, Christian Münz
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 21, pp. 4315-4324
Open Access | Times Cited: 63
The Promise of a Malaria Vaccine—Are We Closer?
Matthew B. Laurens
Annual Review of Microbiology (2018) Vol. 72, Iss. 1, pp. 273-292
Open Access | Times Cited: 60

Scroll to top